International Medical Director - Clinical Development Diabetes

Are you a Medical Doctor (MD) with a solid industry experience and curious about the opportunities at Novo Nordisk? Or you have substantial clinical and research experience – ideally within diabetes and are looking for new challenges? Then, take a look at the opportunities within our Diabetes area!

The position
We are searching for new passionate colleagues to drive a clinical development program and be responsible for supporting the medical strategic direction within Diabetes.

As Medical Specialist you are working at the very heart of our business in Novo Nordisk. You will be involved in developing new therapies for life-threatening diseases, designing clinical trials, evaluating our medicines' safety, and being part of the drug submission and approval processes with health authorities globally. In addition, medical specialists have the critical task of sharing and discussing new insights with physicians and top researchers worldwide. In short, medical specialists at Novo Nordisk play a crucial role in all the different stages of Novo Nordisk's clinical drug development.

In this position you will have a high degree of independence, and decisions taken have a high degree of business impact. In addition, you will collaborate with internal and external stakeholders within Novo Nordisk's global organization and countries all over the globe.

Qualifications
To thrive and succeed, we expect you to have:

It is essential that you have a strong analytical mind-set and good communication and training skills. You are flexible, open-minded and a dedicated team player with the ability to take on an informal leadership role. In addition, you thrive in a global environment of continuous and fast development with focus on high quality and results.

About the department
In Medical & Science Diabetes, we are responsible for the planning and execution of global clinical trials and for medical and scientific support to health authority interactions within the Diabetes portfolio. We are instrumental in providing documentation and interpretation of clinical data leading to New Drug Applications (NDAs) and variation applications, periodic safety updates on marketed drugs, and drugs in clinical development, market access and external scientific communication. The department is based in a project-centric organisation, and internally we work in cross-functional teams. Our key external stakeholders are the scientific community and medical experts, regulatory authorities, and market access institutions.